By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

DelMar Pharmaceuticals 

999 West Broadway
Suite 720
  British Columbia  V5Z 1K5  Canada
Phone: 1-604-629-5989 Fax:


SEARCH JOBS


Industry
Pharmaceutical






Company News
DelMar Pharma To Present At The 18th Annual BIO CEO & Investor Conference On February 8, 2016 2/4/2016 8:14:02 AM
DelMar Pharma To Collaborate With MD Anderson Cancer Center On Development Of DelMar's VAL-083 In Brain Cancer 1/14/2016 11:08:41 AM
DelMar Pharma To Collaborate With MD Anderson Cancer Center On Development Of Delmar's VAL-083 In Brain Cancer 1/13/2016 10:10:57 AM
DelMar Pharma To Present At The Biotech Showcase 2016 On January 12, 2016 1/5/2016 8:53:12 AM
DelMar Pharma Updates VAL-083 Clinical Trial In Refractory Glioblastoma Multiforme At Society For Neuro-Oncology Annual Meeting 11/23/2015 6:42:08 AM
DelMar Pharma To Present At The 8th Annual LD Micro Main Event On December 2, 2015 11/19/2015 8:45:40 AM
DelMar Pharma Reports First Quarter Fiscal Year 2016 Financial Results And Provides Corporate Update 11/17/2015 9:43:20 AM
DelMar Pharma Presents Data Summarizing The Potential Of VAL-083 As A New Treatment Option For Resistant Cancers 11/13/2015 7:10:24 AM
DelMar Pharma Presents Data Supporting VAL-083 As A Promising Potential Treatment For Pediatric Brain Tumors 11/11/2015 6:36:40 AM
DelMar Pharma Presents Positive Data On The Benefit Of VAL-083 In Combination With Platinum-Based Chemotherapy For Non-Small Cell Lung Cancer (NSCLC) 11/10/2015 9:41:40 AM
12345678910...
//-->